FT

Fahim Tanvir

Active Director Director DIN 11433414
DIN 11433414 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Fahim Tanvir

Data last updated:

Fahim Tanvir is a Director at Aerocare Pharma Private Limited (since 2026) and Director at Aroi Compliance Services Private Limited (since 2025).

DIN 11433414
Primary Designation Director
First Appointment 16 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aerocare Pharma Private Limited U46497WR2026PTC295329
Director16 Jul 20262026Active
Director16 Dec 20252025Active

Board colleagues of Fahim Tanvir

Directorship timeline

Open interactive timeline →
Aroi Compliance Services Private Limited
Aerocare Pharma Private Limited
Premium access

Shareholding and investment profile for Fahim Tanvir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fahim Tanvir

Fahim Tanvir currently holds 2 directorships: Aerocare Pharma Private Limited (Director, since 16 Jul 2026); Aroi Compliance Services Private Limited (Director, since 16 Dec 2025).

Fahim Tanvir was first appointed on 16 Dec 2025 as Director at Aroi Compliance Services Private Limited. The most recent appointment on record is 16 Jul 2026 at Aerocare Pharma Private Limited.

The current boards of Fahim Tanvir's companies include Abul Basar (Aerocare Pharma Private Limited), Oindrila Das (Aroi Compliance Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available